Showing results (31-40 of 192) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|November 13, 2008
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytomaAnthony M Joshua, Shereen Ezzat, Sylvia L Asa, et al.
Ocular Oncology and Pathology|November 27, 2019
Conjunctival Melanoma in Childhood and Adolescence: A Systematic ReviewBen W R Balzer, Svetlana Cherepanoff, Anthony M Joshua, et al.
Clinical Genitourinary Cancer|May 14, 2013
Use of a clinical assistant to screen patients with genitourinary cancer to encourage entry into clinical trials and use of supportive medication: a pilot project at a Canadian cancer centerGrace Lun, Eshetu G Atenafu, Jennifer J Knox, et al.
Urologic Oncology|February 19, 2018
Understanding how prostate cancer patients value the current treatment options for metastatic castration resistant prostate cancerTarik Benidir, Karen Hersey, Antonio Finelli, et al.
Melanoma Research|August 2, 2018
Prognostic factors for first-line therapy and overall survival of metastatic uveal melanoma: The Princess Margaret Cancer Centre experienceMathew N Nicholas, Leila Khoja, Eshetu G Atenafu, et al.
Future Science OA|December 20, 2017
Duration of suppression of bone turnover following treatment with zoledronic acid in men with metastatic castration-resistant prostate cancerSaroj Niraula, Arnoud J Templeton, Francisco Vera-Badillo, et al.
Advances in Cancer Research|September 20, 2011
Prostate cancer as a model system for genetic diversity in tumorsJeremy A Squire, Paul C Park, Maisa Yoshimoto, et al.
Ophthalmology. Retina|October 18, 2023
Globe Salvage and Vision Preservation by Neoadjuvant Darovasertib and Crizotinib in Uveal MelanomaAlison Hiong, Roderick O'Day, Lotte S Fog, et al.
Nature Reviews. Clinical Oncology|April 19, 2019
Author Correction: Therapeutic implications of germline genetic findings in cancerSubotheni Thavaneswaran, Emma Rath, Kathy Tucker, et al.
European Journal of Cancer (Oxford, England : 1990)|November 24, 2024
An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanomaJames P Pham, Ramon Staeger, Anthony M Joshua, et al.
Pageof 20